financetom
Business
financetom
/
Business
/
MicroStrategy Completes $603.8 Million Convertible Notes Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MicroStrategy Completes $603.8 Million Convertible Notes Offering
Mar 19, 2024 9:08 AM

11:49 AM EDT, 03/19/2024 (MT Newswires) -- MicroStrategy ( MSTR ) said Tuesday it completed its previously announced offering of 0.875% convertible senior notes due 2031.

A total of $603.8 million of notes were sold in the offering, which includes the full exercise of initial buyers to buy up to an additional $78.8 million of notes, the company said.

MicroStrategy ( MSTR ) said it used the net proceeds of about $592.3 million from the offering to buy additional bitcoin.

The notes will mature on March 15, 2031, the company said.

Shares of the company dropped nearly 13% in recent trading.

Price: 1308.88, Change: -193.88, Percent Change: -12.90

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Veeva Systems Expands Partnership With Roche Pharmaceuticals
Veeva Systems Expands Partnership With Roche Pharmaceuticals
Nov 24, 2025
08:12 AM EST, 11/24/2025 (MT Newswires) -- Veeva Systems ( VEEV ) said Monday that Roche Pharmaceuticals has extended its partnership with the company by integrating Veeva Vault CRM, a deep application for life sciences. Financial terms of the expanded partnership were not disclosed. The Vault CRM platform includes Veeva AI, which features industry-specific AI agents, including Free Text Agent,...
Arrowhead Pharmaceuticals to Receive $200 Million Payment From Sarepta Therapeutics for Meeting ARO-DM1 Milestone
Arrowhead Pharmaceuticals to Receive $200 Million Payment From Sarepta Therapeutics for Meeting ARO-DM1 Milestone
Nov 24, 2025
08:13 AM EST, 11/24/2025 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said Monday that it has earned a $200 million milestone payment from Sarepta Therapeutics ( SRPT ) for meeting a second development milestone event in a phase 1/2 clinical study of ARO-DM1 to treat type 1 myotonic dystrophy. Under the terms of the license and collaboration deal between...
Trubar Q3 Revenue Jumps 88%
Trubar Q3 Revenue Jumps 88%
Nov 24, 2025
08:13 AM EST, 11/24/2025 (MT Newswires) -- Trubar ( TRBRF ) said Monday that third-quarter net revenue and adjusted EBITDA both advanced. The company, which manufactures plant-based protein products, said net revenue jumped 88% to US$21.6 million. Adjusted EBITDA rose to $1.4 million from the $1 million in the previous corresponding quarter. Trubar ( TRBRF ) reaffirmed its full year...
X-energy raises $700 million to expand nuclear reactor projects in US
X-energy raises $700 million to expand nuclear reactor projects in US
Nov 24, 2025
Nov 24 (Reuters) - Nuclear reactor developer X-energy said on Monday it had closed a $700 million financing round led by trading company Jane Street to help expand its supply chain and commercial pipeline. WHY IT'S IMPORTANT The U.S. nuclear industry is undergoing a renaissance after years of stagnation, primarily driven by surging power demand from the so-called hyperscalers that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved